We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
AUM
$1.09B
AUM Growth
-$85.7M
Cap. Flow
+$3.39M
Cap. Flow %
0.31%
Top 10 Hldgs %
27.24%
Holding
2,572
New
1,040
Increased
305
Reduced
301
Closed
890

Sector Composition

Rank Sector Weight
1 Financials 25.23%
2 Technology 13%
3 Healthcare 11.61%
4 Consumer Discretionary 8.1%
5 Industrials 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1301
Lexicon Pharmaceuticals
LXRX
$1.05B
$32K ﹤0.01%
+13,458
New +$37.2K
VRCA icon
1302
Verrica Pharmaceuticals
VRCA
$84.2M
$32K ﹤0.01%
1,083
-1,386
-56% -$47.5K
AGTC
1303
DELISTED
Applied Genetic Technologies Corporation
AGTC
$32K ﹤0.01%
116,488
+105,681
+978% +$46.1K
XELA
1304
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$32K ﹤0.01%
350
+287
+456% +$79.5K
RNWK
1305
DELISTED
RealNetworks Inc
RNWK
$32K ﹤0.01%
+45,898
New +$30.4K
BNR
1306
Burning Rock Biotech
BNR
$103M
$31K ﹤0.01%
+1,314
New +$42.4K
CARM
1307
DELISTED
Carisma Therapeutics
CARM
$31K ﹤0.01%
+3,640
New +$49.6K
DHC
1308
Diversified Healthcare Trust
DHC
$2.02B
$31K ﹤0.01%
+31,164
New +$50K
RDHL
1309
Redhill Biopharma
RDHL
$3.59M
$31K ﹤0.01%
62
+19
+44% +$16.6K
SIDU icon
1310
Sidus Space
SIDU
$260M
$31K ﹤0.01%
+147
New +$44.2K
TTNP
1311
DELISTED
Titan Pharmaceuticals
TTNP
$31K ﹤0.01%
1,417
-1,700
-55% -$43.9K
UGP icon
1312
Ultrapar
UGP
$6.49B
$31K ﹤0.01%
+14,185
New +$35.6K
LMDX
1313
DELISTED
LumiraDx Limited Common Shares
LMDX
$31K ﹤0.01%
30,047
+19,541
+186% +$32.4K
CFRX
1314
DELISTED
ContraFect Corporation
CFRX
$31K ﹤0.01%
+2,277
New +$115K
CDZI icon
1315
Cadiz
CDZI
$298M
$30K ﹤0.01%
+15,899
New +$53.5K
CELU icon
1316
Celularity
CELU
$20.3M
$30K ﹤0.01%
+1,285
New +$39K
FPH icon
1317
Five Point Holdings
FPH
$374M
$30K ﹤0.01%
+11,514
New +$42.1K
GAN
1318
DELISTED
GAN Ltd
GAN
$30K ﹤0.01%
+13,339
New +$40.5K
JAGX icon
1319
Jaguar Health
JAGX
$3.73M
0
WINT
1320
DELISTED
Windtree Therapeutics
WINT
$30K ﹤0.01%
+2
New +$35.7K
XWEL icon
1321
XWELL
XWEL
$8.53M
$30K ﹤0.01%
+1,966
New +$34.8K
VIVS
1322
VivoSim Labs
VIVS
$1.16M
$30K ﹤0.01%
+1,225
New +$39.1K
ANY icon
1323
Sphere 3D
ANY
$17.9M
$29K ﹤0.01%
932
-1,789
-66% -$81.1K
BTOG icon
1324
Bit Origin
BTOG
$3.41M
$29K ﹤0.01%
42
+23
+121% +$16.3K
CIG icon
1325
CEMIG Preferred Shares
CIG
$5.58B
$29K ﹤0.01%
18,626
-238,929
-93% -$411K

Similar funds

Virtu Financial's Q3 2022 Portfolio in Review

As of Q3 2022, Virtu Financial held 2,572 positions worth $1.09B, down 7.3% from $1.18B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Virtu Financial's Q3 2022 filing shows 1,040 new, 305 increased, 301 reduced and 890 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 43,087 shares worth $14.1M. The largest sale was CMC Materials, Inc. Common Stock, an estimated $63M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 8.4% a quarter earlier, followed by Technology and Healthcare.

  • Virtu Financial's largest Q3 2022 buy was Vanguard S&P 500 ETF: 43,087 shares worth $14.1M.
  • Virtu Financial added most to Berkshire Hathaway Class B in Q3 2022, an estimated $129M increase.
  • Virtu Financial's biggest Q3 2022 reduction was SPDR Gold Trust, cutting an estimated $47.4M.
  • Virtu Financial fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $63M.
  • Virtu Financial's ten largest holdings make up 27% of its $1.09B portfolio in Q3 2022.
  • Virtu Financial opened 1,040 new positions and closed 890 in Q3 2022.
  • Virtu Financial's portfolio value fell 7.3% quarter-over-quarter to $1.09B.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.